MS
CRL icon

Madden Securities’s Charles River Laboratories CRL Stock Holding History

Madden Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,200
Closed -$591K – 119
2024
Q4 		$591K Sell
3,200
-2,630
-45% -$507K 0.24% 75
2024
Q3 		$1.15M Sell
5,830
-8,625
-60% -$1.79M 0.5% 50
2024
Q2 		$2.99M Sell
14,455
-1,225
-8% -$278K 1.32% 21
2024
Q1 		$4.25M Sell
15,680
-770
-5% -$184K 1.96% 17
2023
Q4 		$3.89M Sell
16,450
-2,342
-12% -$461K 2.06% 15
2023
Q3 		$3.68M Sell
18,792
-818
-4% -$168K 2.08% 15
2023
Q2 		$4.12M Sell
19,610
-1,141
-5% -$227K 2.11% 18
2023
Q1 		$4.19M Buy
20,751
+1,670
+9% +$378K 2.22% 17
2022
Q4 		$4.16M Buy
19,081
+3,140
+20% +$686K 2.19% 13
2022
Q3 		$3.14M Buy
15,941
+1,902
+14% +$411K 1.9% 17
2022
Q2 		$3M Buy
14,039
+5,729
+69% +$1.4M 1.65% 21
2022
Q1 		$2.36M Buy
8,310
+5,440
+190% +$1.68M 1.06% 27
2021
Q4 		$1.08M Sell
2,870
-40
-1% -$15.5K 0.51% 54
2021
Q3 		$1.2M Sell
2,910
-3,085
-51% -$1.28M 0.65% 48
2021
Q2 		$2.22M Sell
5,995
-200
-3% -$66.8K 1.16% 27
2021
Q1 		$1.79M Sell
6,195
-25
-0.4% -$6.95K 1.05% 30
2020
Q4 		$1.55M Sell
6,220
-65
-1% -$15.5K 1% 34
2020
Q3 		$1.42M Buy
6,285
+2,775
+79% +$576K 1.06% 27
2020
Q2 		$612K Buy
+3,510
New +$560K 0.55% 51
2019
Q4 		$460K Buy
+3,012
New +$417K 0.46% 63

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Madden Securities's CRL Position: Q1 2025 in Review

Madden Securities sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 3,200 shares — an estimated $591K sold.

Madden Securities first reported a position in CRL in Q4 2019 and held it in 20 quarters. The position peaked at $4.25M in Q1 2024. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Madden Securities reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Madden Securities sold 3,200 Charles River Laboratories shares in Q1 2025, an estimated $591K.
  • Madden Securities first reported a position in Charles River Laboratories in Q4 2019 and held it in 20 quarters.
  • Madden Securities's Charles River Laboratories position peaked at $4.25M in Q1 2024.
  • 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Madden Securities's 13F filing for Q1 2025, filed 15 Apr 2025.